يعرض 1 - 10 نتائج من 1,957 نتيجة بحث عن '"2-(N"', وقت الاستعلام: 1.50s تنقيح النتائج
  1. 1
    دورية أكاديمية

    المصدر: IEEE Photonics Journal IEEE Photonics J. Photonics Journal, IEEE. 15(6):1-7 Dec, 2023

  2. 2
  3. 3
    مؤتمر

    المصدر: 2022 57th International Scientific Conference on Information, Communication and Energy Systems and Technologies (ICEST) Information, Communication and Energy Systems and Technologies (ICEST), 2022 57th International Scientific Conference on. :1-3 Jun, 2022

    Relation: 2022 57th International Scientific Conference on Information, Communication and Energy Systems and Technologies (ICEST)

  4. 4
  5. 5
    دورية أكاديمية

    المؤلفون: Wang, Yi-FanAff1, Aff2, Xie, Bin, Zou, Ying-XueAff2, IDs10653023016148_cor3

    المصدر: Environmental Geochemistry and Health: Official Journal of the Society for Environmental Geochemistry and Health. 45(8):5981-5990

  6. 6
    كتاب إلكتروني

    المؤلفون: Pardasani, R. T.Aff1, Pardasani, P.Aff2

    المساهمون: Pardasani, R. T.Aff10, Pardasani, P.Aff20

    المصدر: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 7 : A Supplement to Landolt-Börnstein II/31 Series. :124-127

  7. 7
    دورية أكاديمية

    المؤلفون: Razani, R., Ravanji, M.H., Parniani, M.

    المصدر: IEEE Transactions on Power Electronics IEEE Trans. Power Electron. Power Electronics, IEEE Transactions on. 34(4):3139-3149 Apr, 2019

  8. 8
    دورية أكاديمية

    المصدر: Acta pharmaceutica Sinica. B. 10(1)

    مصطلحات موضوعية: 2-NBDG, 2-[N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl) amino]-2-deoxyglucose, ABCG2, ATP-binding cassette subfamily G member 2, ACN, acetonitrile, Au/Uv, absorbance unit of ultraviolet-visible spectroscopy, BCRP, breast cancer resistant protein, BERA, bioengineered miRNA agent, Bioengineered RNA, CI, combination index, CPT, cisplatin, Cancer, Chemosensitivity, DOX, doxorubicin, E. coli, Escherichia coli, ESI, electrospray ionization, FPLC, fast protein liquid chromatography, Fa, fraction affected, GLUT1, GLUT1, glucose transporter protein type 1, HCC, hepatocellular carcinoma, HPLC, high-performance liquid chromatography, IS, internal standard, KRB, Krebs–Ringer bicarbonate, LAT1, LAT1, large neutral amino acid transporter 1, LC–MS/MS, liquid chromatography–tandem mass spectroscopy, MCT4, monocarboxylate transporter 4, MRE, miRNA response elements, MRM, multiple reaction monitoring, MiR-328, OS, osteosarcoma, PAGE, polyacrylamide gel electrophoresis, PTEN, phosphatase and tensin homolog, PVDF, Polyvinylidene fluoride, RAGE, receptor for advanced glycosylation end products, RT-qPCR, reverse transcription quantitative real-time polymerase chain reaction, SLC2A1, 7A5, 16A3, solute carrier family 2 member 1, family 7 member 5, family 16 member 3, WT, wild type, hBERA, humanized bioengineered miRNA agent, hsa, Homo sapiens, htRNASer, human seryl-tRNA, mTOR, mammalian target of rapamycin, miR or miRNA, microRNA, ncRNA, noncoding RNAs, nt, nucleotide, LATI, 2-NBDG, 2-[N-(7-nitrobenz-2-oxa-1, 3-diazol-4-yl) amino]-2-deoxyglucose, ABCG2, ATP-binding cassette subfamily G member 2, ACN, acetonitrile, Au/Uv, absorbance unit of ultraviolet-visible spectroscopy, BCRP, breast cancer resistant protein, BERA, bioengineered miRNA agent, CI, combination index, CPT, cisplatin, DOX, doxorubicin, E. coli, Escherichia coli, ESI, electrospray ionization, FPLC, fast protein liquid chromatography, Fa, fraction affected, glucose transporter protein type 1, HCC, hepatocellular carcinoma, HPLC, high-performance liquid chromatography, IS, internal standard, KRB, Krebs–Ringer bicarbonate, large neutral amino acid transporter 1, LC–MS/MS, liquid chromatography–tandem mass spectroscopy, MCT4, monocarboxylate transporter 4, MRE, miRNA response elements, MRM, multiple reaction monitoring, OS, osteosarcoma, PAGE, polyacrylamide gel electrophoresis, PTEN, phosphatase and tensin homolog, PVDF, Polyvinylidene fluoride, RAGE, receptor for advanced glycosylation end products, RT-qPCR, reverse transcription quantitative real-time polymerase chain reaction, SLC2A1, 7A5, 16A3, solute carrier family 2 member 1, family 7 member 5, family 16 member 3, WT, wild type, hBERA, humanized bioengineered miRNA agent, hsa, Homo sapiens, htRNASer, human seryl-tRNA, mTOR, mammalian target of rapamycin, miR or miRNA, microRNA, ncRNA, noncoding RNAs, nt, nucleotide, Nutrition, Biotechnology, Genetics, 1.1 Normal biological development and functioning

  9. 9
    كتاب إلكتروني

    المؤلفون: Pardasani, R. T.Aff1, Pardasani, P.Aff2

    المساهمون: Pardasani, R. T.Aff10, Pardasani, P.Aff20

    المصدر: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 8 : A Supplement to Landolt-Börnstein II/31 Series. :784-786

  10. 10
    كتاب إلكتروني

    المؤلفون: Pardasani, R. T.Aff1, Pardasani, P.Aff2

    المساهمون: Pardasani, R. T.Aff10, Pardasani, P.Aff20

    المصدر: Magnetic Properties of Paramagnetic Compounds, Magnetic Susceptibility Data, Volume 8 : A Supplement to Landolt-Börnstein II/31 Series. :787-789